Latest Breaking News On - Development rd expense - Page 3 : comparemela.com

Exicure, Inc Reports Full Year 2022 Financial Results and Provides Corporate Update

CHICAGO (BUSINESS WIRE) Mar 27, 2023

United statesMatthias schroffKaren sharmaSeung soo shinExchange commissionCompany annual report on formExchange commission onDevelopment rd expenseExicure incGiven the companyUnited states incPrivate placementChief executive officerAbbvie collaboration agreementIpsen collaboration agreementPrivate securities litigation reform act

Exicure, Inc Reports Full Year 2022 Financial Results and Provides Corporate Update

Exicure, Inc Reports Full Year 2022 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKaren sharmaMatthias schroffSeung soo shinCompany annual report on formGiven the companyDevelopment rd expenseExchange commissionExchange commission onExicure incUnited states incPrivate placementChief executive officerAbbvie collaboration agreementIpsen collaboration agreementPrivate securities litigation reform act

Exicure, Inc Reports Third Quarter 2022 Financial Results and Provides Corporate Update

CHICAGO (BUSINESS WIRE) Nov 14, 2022

United statesKaren sharmaMatthias schroffDevelopment rd expenseIpsen biopharmExchange commission onExicure incExchange commissionCompany at corporateUnited states incGiven the companyAbbvie incCompany quarterly report on formPrivate placementChief executive officerIpsen biopharm limited

C4 Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights

C4 Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCourtney solbergBriana vanLoraine spreenAndrew hirschDevelopment rd expenseCorporate communications patient advocacyCredit suisseResearch activitiesDrug administrationSiteman cancer centerWashington university school of medicineExchange commissionTherapeutics incConnective tissue oncology societyDivision of oncology

Exicure, Inc Reports Second Quarter 2022 Financial Results and Corporate Progress

CHICAGO (BUSINESS WIRE) Aug 15, 2022

United statesKaren sharmaMatthias schroffDevelopment rd expenseExchange commission onIpsen biopharmExicure incCompany annual report on formExchange commissionUnited states incGiven the companyAbbvie incChief executive officerRestated certificateNasdaq capital marketIpsen biopharm limited